Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 02, 2015 6:47 PM ET

Biotechnology

Company Overview of DBV Technologies S.A.

Executive Profile

Paul Henri Lambert

Member of the Scientific Advisory Board, DBV Technologies S.A.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Paul Henri Lambert serves as Chairman of Scientific Advisory Board at GlycoVaxyn AG. Professor Lambert serves as Member of Scientific Advisory Board at DBV Technologies. He serves as Chairman for the Global Advisory Committee for Vaccine Safety (GACVS) at the World Health Organisation (WHO). From 2000 to 2004, Professor Lambert was Coordinator of the European Commission's European project on the Improvement of Neonatal Vaccination and was the Chairman of the European ...

Corporate Headquarters

Green Square
Bagneux, Ile-de-France 92220

France

Phone: 33 1 55 42 78 78
Fax: 33 1 43 26 10 83

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
Université de Liège

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Carlos V. Paya M.D., Ph.D.Chief Executive Officer, President and Director
Immune Design Corp.
$798.3K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DBV Technologies S.A., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.